Endocannabinoids as potential biomarkers: It‘s all about pre-analytics
Introduction: Arachidonoyl ethanolamide (AEA) and 2-arachidonoyl glycerol (2-AG) are central lipid mediators of the endocannabinoid system. They are highly relevant due to their involvement in a wide variety of inflammatory, metabolic or malign diseases. Further elucidation of their modes of action...
Enregistré dans:
Auteurs principaux: | Daniel Kratz, Dominique Thomas, Robert Gurke |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/be8230d40d024b6cb65f0df779c1cb6a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of Sprague Dawley rats
par: Aidan Levine, et autres
Publié: (2021) -
Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage
par: López Marta Gómez, et autres
Publié: (2020) -
ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
par: Fabio MAYORGA N., et autres
Publié: (2009) -
Management of post-analytical processes in the clinical laboratory according to ISO 15189:2012. Considerations about the management of clinical samples, ensuring quality of post-analytical processes, and laboratory information management
par: López Yeste Mᵃ Libòria, et autres
Publié: (2021) -
Prediabetes: what are we talking about?
par: Escalada San Martín Javier
Publié: (2021)